Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Short term Debt (2016 - 2020)

Fortress Biotech has reported Short term Debt over the past 5 years, most recently at $413000.0 for Q2 2020.

  • Quarterly results put Short term Debt at $413000.0 for Q2 2020, changed N/A from a year ago — trailing twelve months through Jun 2020 was $413000.0 (changed N/A YoY), and the annual figure for FY2019 was $27000.0, down 97.28%.
  • Short term Debt for Q2 2020 was $413000.0 at Fortress Biotech, up from $69000.0 in the prior quarter.
  • Over the last five years, Short term Debt for FBIO hit a ceiling of $991000.0 in Q4 2018 and a floor of $16000.0 in Q1 2019.
  • Median Short term Debt over the past 5 years was $302000.0 (2016), compared with a mean of $328466.7.
  • Biggest five-year swings in Short term Debt: crashed 97.28% in 2019 and later soared 331.25% in 2020.
  • Fortress Biotech's Short term Debt stood at $481000.0 in 2016, then plummeted by 35.76% to $309000.0 in 2017, then soared by 220.71% to $991000.0 in 2018, then crashed by 97.28% to $27000.0 in 2019, then soared by 1429.63% to $413000.0 in 2020.
  • The last three reported values for Short term Debt were $413000.0 (Q2 2020), $69000.0 (Q1 2020), and $27000.0 (Q4 2019) per Business Quant data.